155 related articles for article (PubMed ID: 22076223)
1. Role of F-fluoro-2-deoxyglucose Positron Emission Tomography in Gastric GIST: Predicting Malignant Potential Pre-operatively.
Park JW; Cho CH; Jeong DS; Chae HD
J Gastric Cancer; 2011 Sep; 11(3):173-9. PubMed ID: 22076223
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.
Tokumoto N; Tanabe K; Misumi T; Fujikuni N; Suzuki T; Ohdan H
Dig Surg; 2014; 31(2):79-86. PubMed ID: 24776690
[TBL] [Abstract][Full Text] [Related]
3. [The value of (18)F-FDG PET-CT imaging in predicting the malignant potential of GIST].
Li SX; Tang MD; Lin DY; Liu DJ; Lyu QH; Zhang JP; Cai ZH
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):821-827. PubMed ID: 29151288
[No Abstract] [Full Text] [Related]
4. Value of
Li S; Lin D; Tang M; Liu D; Lyu Q; Zhang J
J Gastrointest Oncol; 2022 Apr; 13(2):637-646. PubMed ID: 35557562
[TBL] [Abstract][Full Text] [Related]
5. Malignant diagnosis and prognostic analysis of 89 GIST patients using preoperative FDG-PET.
Narushima K; Shuto K; Okazumi S; Ohira G; Mori M; Hayano K; Yanagawa N; Matsubara H
Sci Rep; 2023 Feb; 13(1):2266. PubMed ID: 36755154
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors.
Kamiyama Y; Aihara R; Nakabayashi T; Mochiki E; Asao T; Kuwano H; Oriuchi N; Endo K
World J Surg; 2005 Nov; 29(11):1429-35. PubMed ID: 16222452
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Gastric Mesenchymal Tumors.
Iwamuro M; Miyahara K; Sakaguchi C; Takenaka R; Kobayashi S; Mouri H; Tanaka S; Toyokawa T; Tanaka S; Nishimura M; Yamauchi K; Tanaka T; Okada H
J Clin Med; 2020 May; 9(5):. PubMed ID: 32370028
[TBL] [Abstract][Full Text] [Related]
9. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
Ohara M; Shigematsu H; Tsutani Y; Emi A; Masumoto N; Ozaki S; Kadoya T; Okada M
Breast; 2013 Oct; 22(5):958-63. PubMed ID: 23756383
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative
Hwang SH; Jung M; Jeong YH; Jo K; Kim S; Wang J; Cho A
Cancer Metab; 2021 Jan; 9(1):8. PubMed ID: 33509304
[TBL] [Abstract][Full Text] [Related]
11. Gastric GIST malignancy evaluated by 18FDG-PET as compared with EUS-FNA and endoscopic biopsy.
Yamada M; Niwa Y; Matsuura T; Miyahara R; Ohashi A; Maeda O; Ando T; Ohmiya N; Itoh A; Hirooka Y; Goto H
Scand J Gastroenterol; 2007 May; 42(5):633-41. PubMed ID: 17454885
[TBL] [Abstract][Full Text] [Related]
12. Correlation of
Mayoral M; Paredes P; Saco A; Fusté P; Perlaza P; Tapias A; Fernandez-Martinez A; Vidal L; Ordi J; Pavia J; Martinez-Roman S; Lomeña F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):80-86. PubMed ID: 28869177
[TBL] [Abstract][Full Text] [Related]
13. Correlation of 18F-fluorodeoxyglucose uptake on positron emission tomography with Ki-67 index and pathological invasive area in lung adenocarcinomas 30 mm or less in size.
Murakami S; Saito H; Sakuma Y; Mizutani Y; Ishikawa Y; Kondou T; Oshita F; Yokose T; Kameda Y; Suga Y; Ito H; Tsuboi M; Nakayama H; Noda K; Yamada K
Eur J Radiol; 2010 Aug; 75(2):e62-6. PubMed ID: 20005653
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG-PET/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors.
Ito T; Suzuki H; Sakairi Y; Wada H; Nakajima T; Yoshino I
Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):274-281. PubMed ID: 32734427
[TBL] [Abstract][Full Text] [Related]
16. Correlation of
Mitamura K; Yamamoto Y; Norikane T; Hatakeyama T; Okada M; Nishiyama Y
Ann Nucl Med; 2018 Nov; 32(9):627-633. PubMed ID: 30032455
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.
Albano D; Bertoli M; Ferro P; Fallanca F; Gianolli L; Picchio M; Giubbini R; Bertagna F
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):589-597. PubMed ID: 27619357
[TBL] [Abstract][Full Text] [Related]
18. Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging.
Yue Y; Cui X; Bose S; Audeh W; Zhang X; Fraass B
Breast Cancer Res Treat; 2015 Oct; 153(3):607-16. PubMed ID: 26346756
[TBL] [Abstract][Full Text] [Related]
19. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of PET-CT for predicting the malignant potential of gastrointestinal stromal tumors.
Yoshikawa K; Shimada M; Kurita N; Sato H; Iwata T; Morimoto S; Miyatani T; Kashihara H; Takasu C; Matsumoto N
Surg Today; 2013 Oct; 43(10):1162-7. PubMed ID: 23143169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
